OpenVSafe by OpenVAERS
Search V-safe

EC4-24286-71472

4 vaccinations 13 coded responses 54 check-ins 13 free-text entries 0 call cases
Sex
Female
Age at first dose
36-40
ZIP prefix
130 / NY
Registered
2021-01-28
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-28
    Registered in v-safe
  2. 2021-01-28
    Dose 1 — Pfizer-BioNTech
  3. 2021-01-28
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain · Headache, Diarrhea
    Adult check-in
  4. 2021-01-29
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-01-30
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  6. 2021-01-31
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  7. 2021-02-01
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-02-02
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-02-03
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-02-04
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2021-02-11
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-02-18
    Dose 2 — Pfizer-BioNTech
  13. 2021-02-18
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain, Redness · None
    Adult check-in
  14. 2021-02-19
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Diarrhea
    Adult check-in
  15. 2021-02-20
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Nausea
    Adult check-in
  16. 2021-02-21
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain, Redness, Swelling · Fever · None
    Adult check-in
  17. 2021-02-22
    Survey response — days 1–6 daily, dose 2
    MedDRA: Feeling hot, Mass, Pain, Rash — Feeling: Good · Site: Pain, Redness, Swelling
    Free text: Developed a visible, mildly painful lump yesterday near injection site/where I have a mild rash; arm from that area up to the shoulder is also much warmer to the touch compared to the rest of my arm.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-02-23
    Survey response — days 1–6 daily, dose 2
    MedDRA: Injection site erythema, Injection site mass, Injection site rash — Feeling: Good · Site: Pain, Redness, Swelling
    Free text: Still have a lump in same area as mild redness/rash near injection site
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-02-24
    Survey response — days 1–6 daily, dose 2
    MedDRA: Injection site mass, Injection site rash — Feeling: Good · Site: Redness, Swelling · Headache
    Free text: Lump and mild rash near injection site have lessened.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  20. 2021-02-25
    Survey response — day 7, dose 2
    MedDRA: Injection site rash, Yellow skin — Feeling: Good · Site: Swelling
    Free text: Rash near injection site is virtually gone, lump still present but greatly reduced
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  21. 2021-03-04
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-03-11
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-03-18
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-03-25
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-04-01
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-05-20
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-08-19
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  28. 2021-10-02
    Dose 3 — Pfizer-BioNTech
  29. 2021-10-02
    Health check-in — day 0, dose 3
    Feeling: Good · None
    Adult check-in
  30. 2021-10-03
    Survey response — days 1–6 daily, dose 3
    MedDRA: Injection site induration — Feeling: Good · Site: Pain, Redness
    Free text: Area around injection site is firm.
    MedDRA releases: 2024-11 · check-in free text available
  31. 2021-10-04
    Survey response — days 1–6 daily, dose 3
    MedDRA: Injection site induration — Feeling: Good · Site: Pain, Redness
    Free text: Area around injection site is still slightly firm to the touch
    MedDRA releases: 2024-11 · check-in free text available
  32. 2021-10-05
    Survey response — days 1–6 daily, dose 3
    MedDRA: Injection site induration — Feeling: Good · Site: Pain, Redness
    Free text: Firmness around injection site nearly gone
    MedDRA releases: 2024-11 · check-in free text available
  33. 2021-10-06
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain, Redness, Itching · None
    Adult check-in
  34. 2021-10-07
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Redness · None
    Adult check-in
  35. 2021-10-09
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  36. 2021-10-16
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  37. 2021-10-23
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  38. 2021-10-30
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  39. 2021-11-06
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  40. 2021-11-13
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  41. 2022-01-01
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  42. 2022-04-02
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  43. 2022-10-02
    Health check-in — 12 months, dose 3
    Feeling: Good
    Adult check-in
  44. 2022-10-29
    Dose 4 — Pfizer-BioNTech
  45. 2022-10-29
    Health check-in — day 0, dose 4
    Feeling: Good · Site: Pain · None
    Adult check-in
  46. 2022-10-30
    Survey response — days 1–6 daily, dose 4
    MedDRA: Injection site pain — Feeling: Good · Site: Pain, Redness, Itching
    Free text: Tender at the site of injection
    MedDRA releases: 2024-11 · check-in free text available
  47. 2022-10-31
    Survey response — days 1–6 daily, dose 4
    MedDRA: Injection site erythema, Injection site mass, Injection site pain, Injection site warmth — Feeling: Good · Site: Pain, Redness, Swelling, Itching
    Free text: Redness surface area has increased, area is still warm and tender to the touch, visible and palpable lump at injection site area
    MedDRA releases: 2024-11 · check-in free text available
  48. 2022-11-01
    Survey response — days 1–6 daily, dose 4
    MedDRA: Injection site erythema, Injection site mass, Injection site pruritus, Injection site warmth — Feeling: Good · Site: Pain, Redness, Swelling, Itching
    Free text: Red area around injection site is still large, though not as vibrant. Still visible and palpable lump, though less so. Arm is still warm to the touch at injection site, and occasional mild itching still persists.
    MedDRA releases: 2024-11 · check-in free text available
  49. 2022-11-02
    Survey response — days 1–6 daily, dose 4
    MedDRA: Erythema, Pruritus, Swelling, Tenderness — Feeling: Good · Site: Pain, Redness, Swelling, Itching
    Free text: Itching, redness, tenderness, and swelling all noticeably reduced.
    MedDRA releases: 2024-11 · check-in free text available
  50. 2022-11-03
    Survey response — days 1–6 daily, dose 4
    MedDRA: Adverse reaction — Feeling: Good · Site: Redness, Itching
    Free text: Side effects are largely gone
    MedDRA releases: 2024-11 · check-in free text available
  51. 2022-11-04
    Survey response — days 1–6 daily, dose 4
    MedDRA: Adverse reaction — Feeling: Good · Site: Redness, Itching
    Free text: All side effects are nearly gone.
    MedDRA releases: 2024-11 · check-in free text available
  52. 2022-11-05
    Health check-in — day 7, dose 4
    Feeling: Good · None
    Adult check-in
  53. 2022-11-12
    Health check-in — day 14, dose 4
    Feeling: Good
    Adult check-in
  54. 2022-11-19
    Health check-in — day 21, dose 4
    Feeling: Good
    Adult check-in
  55. 2022-11-26
    Health check-in — day 28, dose 4
    Feeling: Good
    Adult check-in
  56. 2022-12-03
    Health check-in — day 35, dose 4
    Feeling: Good
    Adult check-in
  57. 2022-12-10
    Health check-in — day 42, dose 4
    Feeling: Good
    Adult check-in
  58. 2023-01-30
    Health check-in — 3 months, dose 4
    Feeling: Good
    Adult check-in
  59. 2023-04-29
    Health check-in — 6 months, dose 4
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-01-28Pfizer-BioNTech
22021-02-18Pfizer-BioNTech
32021-10-02Pfizer-BioNTech No
42022-10-29Pfizer-BioNTech No

Free text

Release 4 — days 1–6 daily, dose 2

2021-02-22

Systemic reaction (other): Developed a visible, mildly painful lump yesterday near injection site/where I have a mild rash; arm from that area up to the shoulder is also much warmer to the touch compared to the rest of my arm.

2021-02-23

Systemic reaction (other): Still have a lump in same area as mild redness/rash near injection site

2021-02-24

Systemic reaction (other): Lump and mild rash near injection site have lessened.

Release 4 — day 7, dose 2

2021-02-25

Systemic reaction (other): Rash near injection site is virtually gone, lump still present but greatly reduced

Release 9 — days 1–6 daily, dose 3

2021-10-03

Systemic reaction (other): Area around injection site is firm.

Release 10 — days 1–6 daily, dose 3

2021-10-04

Systemic reaction (other): Area around injection site is still slightly firm to the touch

2021-10-05

Systemic reaction (other): Firmness around injection site nearly gone

Release 12 — days 1–6 daily, dose 4

2022-10-30

Systemic reaction (other): Tender at the site of injection

2022-10-31

Systemic reaction (other): Redness surface area has increased, area is still warm and tender to the touch, visible and palpable lump at injection site area

2022-11-01

Systemic reaction (other): Red area around injection site is still large, though not as vibrant. Still visible and palpable lump, though less so. Arm is still warm to the touch at injection site, and occasional mild itching still persists.

2022-11-02

Systemic reaction (other): Itching, redness, tenderness, and swelling all noticeably reduced.

2022-11-03

Systemic reaction (other): Side effects are largely gone

2022-11-04

Systemic reaction (other): All side effects are nearly gone.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SROAdverse reaction · · ✓
SROErythema · · ✓
SROFeeling hot ✓ ✓ ✓
SROInjection site erythema ✓ ✓ ✓
SROInjection site induration · · ✓
SROInjection site mass ✓ ✓ ✓
SROInjection site pain · · ✓
SROInjection site pruritus · · ✓
SROInjection site rash ✓ ✓ ✓
SROInjection site warmth · · ✓
SROMass ✓ ✓ ✓
SROPain ✓ ✓ ✓
SROPruritus · · ✓
SRORash ✓ ✓ ✓
SROSwelling · · ✓
SROTenderness · · ✓
SROYellow skin ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release